Skip to main content

Biodiversity treaty called disastrous

Scientists complain that restrictions on access hinder research, undercut development goals

Written byTed Agres
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00

The first legally binding international agreement governing the shipment of genetically modified organisms (GMO) across borders goes into effect tomorrow (September11). The Cartagena Protocol on Biosafety requires that the governments of signatory nations be notified when living GMOs, such as crop plants, are going to be brought into the country with the intention of introducing them into the environment.

Critics are already expressing concern about possible trade consequences of the new rules, which are intended to protect native biodiversity, but the protocol is not expected to significantly impact scientific research. However, the biosafety protocol is only one part of a larger treaty, the Convention on Biological Diversity (CBD), which also covers access to indigenous plants and other genetic resources, and so far, scientists and others say, the protocol's parent document has proved misguided at best.

"The treaty is an absolute disaster for scientists," said a senior UN official on condition ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays